Table 1.
Characteristics of included patients categorized by disease stage.
| Mild < 1600 ml (n = 26) | Moderate 1600–3200 ml (n = 33) | Severe >3200 ml (n = 23) | p value | |
|---|---|---|---|---|
| Age, median (IQR), years | 48 (33–57) | 49 (46–57) | 43 (40–56) | 0.232b |
| Female, n (%) | 18 (69) | 28(85) | 21 (91) | 0. 114c |
| Diagnosis ADPKD, n (%) | 24 (92) | 24 (73) | 17 (52) | 0.139c |
| HtLV (ml/m), median (IQR) | 1087 (924–1306) | 2375 (1941–2754) | 4571 (3868–5411) | 0.002b |
| HtKV (ml/m), median (IQR)a | 801 (374–1191) | 836 (361–1275) | 614 (380–1480) | 0.258b |
| Renal function (eGFR), median (IQR)a | 73 (44–86) | 64 (46–77) | 71 (54–84) | 0.177b |
a
Kidney volumes and renal function of ADPKD patients only. P values tested with bKruskal-Wallis test or cChi-Square test. eGFR: estimated glomerular filtration rate using the Modification of Diet in Renal Disease formula; ADPKD: autosomal dominant polycystic kidney disease; htKV: height-corrected kidney volume; htLV: height-corrected liver volume; IQR: interquartile range.